ZENITH A011-14 (A Phase 3, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) WorldHealth Organization (WHO)
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Acceleron Pharma
Start Date
July 20, 2022
End Date
February 14, 2026
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Acceleron Pharma
Start Date
July 20, 2022
End Date
February 14, 2026